No Data
No Data
Express News | Polyrizon Commences Gmp Manufacturing Preliminary Process for Its Pl-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
Polyrizon Preparing For Clinical Trial Of PL-14 In 2025
Polyrizon Partners With Eurofins CDMO Amatsiaquitaine S.A.S. for GMP Manufacturing Support Ahead of 2025 Clinical Trial
Polyrizon Commences GMP Manufacturing Preliminary Process for Its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
Express News | Polyrizon Ltd: Files Prospectus Related to Resale by Selling Shareholders of up to 2.4 Mln Ordinary Shares - SEC Filing
Why Is Development-Stage Biotech Company Polyrizon Stock Surging Today?